Early vs. late stopping of antibiotics for fever in blood cancer treatment
Part of Blood & lymphatic, Cancer, Infections clinical trials.
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are receiving chemotherapy for a stem cell transplant, CAR T-cell therapy, or induction therapy for acute leukemia
- You developed a fever (temperature at least 38°C or 100.4°F) during treatment
- Your fever went away and stayed gone for at least 48 hours but less than 96 hours
- You have not had a positive blood culture or other infection needing antibiotics since the fever started
- You do not have severe mouth sores or an inflamed gut from treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an antibiotic called dalbavancin, given to prevent bacterial infections during chemotherapy-induced low white blood cell counts, is safe and works in children and young adults with certain types of leukemia. It may help reduce the risk of serious infections during treatment.
This trial tests whether it is safe to stop antibiotics earlier than usual in patients with a low white blood cell count (neutropenia) who have had a fever but have been fever-free for 48 hours. The goal is to reduce unnecessary antibiotic use and its side effects.
This study looks at how long antibiotics should be given to cancer patients with fever and very low white blood cell counts after finding a certain type of bacteria (Gram-negative) in their blood. The goal is to find the best treatment duration to help patients recover without complications.
This trial tests whether it is safe to stop antibiotics earlier than usual in children with cancer who have a fever and very low white blood cell counts, if they are at low risk of serious infection. The goal is to reduce unnecessary antibiotic use and its side effects.
This study looks at whether doctors can safely use fewer/less intense antibiotics after fever improves in adults with low white blood cell counts after a stem cell transplant. It may help reduce unnecessary antibiotic exposure while still treating serious infections.
This study looks at how antibiotics are used in the emergency department for patients who may have a low white blood cell count (neutropenic fever) after cancer treatment. The goal is to ensure antibiotics are used appropriately and effectively without causing harm.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.